# VEKADE PHARMA LIMITED (07179980)

> VEKADE PHARMA LIMITED is an active private limited company (company number 07179980) incorporated on 5 March 2010, registered in Watford. Its registered activity is other professional, scientific and technical activities n.e.c. (SIC 74909). Latest small accounts cover the period ending 31 March 2025, showing net assets of £25k and cash of £14k, with 3 employees on average. Net assets rose 11% on the prior period (£23k).

- Status: Active
- Incorporated: 2010-03-05
- Registered office: Watford, WD24 7ND
- SIC 74909: Other professional, scientific and technical activities n.e.c.
- Next accounts due: 2026-12-31
- Confirmation statement due: 2027-03-19
- Accounts type: TOTAL EXEMPTION FULL

By net assets it sits in the upper half of 3,982 comparable companies in Greater London (median £6,072, upper quartile £45k).

## Accounts (as filed)

| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 2025-03-31 | £25k | £14k | £79k | £148k | — | — | 3 |
| 2024-03-31 | £23k | £26k | £126k | £190k | — | — | 3 |

current ratio 0.91; size band micro.

## Filing and accounts signals (facts, not a rating)

- Net assets above zero: Net assets £24,995 at 31 March 2025
- Net assets up 10% or more on the prior period: +10.8% vs prior period
- Current assets below creditors within one year: Current ratio 0.91
- Incorporated five or more years ago: Incorporated 5 March 2010

How each signal is derived: https://firmoscan.com/methodology

## Persons with significant control

- Mr Kanjikumar Bavanjibhai Mandanka — owns 75–100% of shares, since 2016-04-06

---
Source: Companies House register snapshot 2026-08-31, Open Government Licence v3.0. Information may have changed since that date and is not advice or a credit reference; check the official record before relying on it. Official record: https://find-and-update.company-information.service.gov.uk/company/07179980
HTML: https://firmoscan.com/company/07179980-vekade-pharma-limited
